To evaluate the efficacy of antiageing cream.

Phase 2

Completed

• Registration Number: CTRI/2017/12/011027
• Lead Sponsor: Dabur India Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2011-10-07
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 32

Inclusion Criteria

1.subjects in generally good health

2.Subjects in the age group of 30-50 years.

3.Subjects should have minimum number of fine lines, mild to moderate.

4.Subjects having a wrinkle and five volunteers with deep wrinkles will be selected for visiometer.

5.Must have at least 2 hyperpigmentation lesions (freckles, lentigen, periorbital melanosis) each at least 3mm on the face. Subjects who exhibit moderate hyperpigmentation with a score of 3 but no greater than 4 (see scale in section 7.3.D.1).

6.Subject has not participated in a similar investigation in the past four weeks.

7.Subjects have not used a similar product for the last four weeks.

8.Subjects willing to give a written informed consent and come for regular follow.

Exclusion Criteria

1.Subjects with known allergies or sensitivities to cosmetic products, toiletries or its components like fragrances, preservatives, hydroquinone, vitamin C, Niacin amide, retinol, soy etc.

2.Currently or has been using topical retinoids, alpha-hydroxy and/or beta-hydroxy acids, hydroquinone or any whitening/Fairness preparation in any form (cleanser, toner, facial lotion, cream or soaps) within the last 1 month.

3. Currently or has been undergoing dermatologist facial treatments or procedures within the last 1 month.

4.Currently or has been involved in another facial skin care clinical investigation within the last 3 months.

5.Subjects who have pre-existing or dormant facial dermatologic conditions (e.g., psoriasis, rosacea, rashes, eczema, many and/or severe excoriations etc.) that could interfere with the outcome of the study as determined by the investigator.

6.Subjects with excessive facial hair or scars (including acne scars), which could interfere with expert grader and/or instrumental evaluations.

7.Subjects having melasma and severe photo damage.

8.Subjects who are nursing as determined by the investigator interview during screening or pregnant as determined by the Urine pregnancy testing after screening.

9.Subjects viewed by the investigator as not being able to complete the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified